Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results
-
FreshBooks and Bluevine Partner to Help U.S. Small Business Owners Simplify Financial Management
-
Bread Financial Announces $600 Million Increase in Share Repurchase Authority
-
InflaRx Announces Participation in the Leerink Partners Global Healthcare Conference
-
Olenox Industries Subsidiary Giant Containers Retained for Development of New Jersey’s Newest State Park
-
Annual general meeting of Realkredit Danmark A/S
-
Diana Shipping Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2025; and Declares Cash Dividend of $0.01 Per Common Share for the Fourth Quarter 2025
-
Exodus Movement, Inc. to Announce Fourth Quarter and Full Year 2025 Results on March 11, 2026
-
UK-China talks on Thermobalancing therapy for kidney stones, enlarged/inflamed prostate, back pain and joints problems
-
Anika Reports Fourth Quarter and Full Year 2025 Financial Results
-
The Joint Corp. to Report 2025 Fourth Quarter and Full Year Results on Thursday, March 12 and Host Conference Call and Webcast
-
Conavi Medical Reports Fiscal First Quarter 2026 Results and Operational Highlights
-
Gilat Demonstrates 5G NTN End-to-End Connectivity over GEO Satellite
-
VR Farms Out its Copper-Nickel-PGM Properties in Ontario, and Dials in Exploration and Drill Planning in Nevada
-
Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Financial Results and Business Update Conference Call on March 5, 2026
-
KingKonree Expands ADA Sink Solutions to Support Inclusive Design Across North American Commercial Projects
-
BioCryst Reports Full Year 2025 Financial Results and Provides Business Update
-
Akebia Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Commercial and Pipeline Highlights
-
Ligand Reports Fourth Quarter and Full Year 2025 Financial Results
-
Carlyle Presents Growth Outlook at 2026 Shareholder Update
-
Kymera Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
-
Joint Press Release of Future Fuels Inc. and ValOre Metals Corp. – Future Fuels Inc. Enters Into Agreement to Acquire Hatchet Uranium Corp.
-
TG Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Raises BRIUMVI Revenue Guidance
-
Upstream Bio to Present Additional Analyses from Phase 2 VIBRANT Trial in Chronic Rhinosinusitis with Nasal Polyps in Late-Breaking Session at AAAAI Annual Meeting 2026
-
Good Supply Cannabis Brand Expands High-Potency Portfolio with New Spring Lineup Across Canada
-
ACM Research Reports Fourth Quarter and Fiscal Year 2025 Results
-
ACM Research Receives Multiple Advanced Packaging Equipment Orders from Leading Global Customers
-
ACM Research Delivers Multiple Single-Wafer Cleaning Systems to Foundry Customer in Singapore
-
Luckin Coffee Announces Fourth Quarter and Fiscal Year 2025 Financial Results
-
AtaiBeckley Announces Positive Topline Results from an Exploratory Phase 2a Trial of EMP-01 (oral R-MDMA) in Social Anxiety Disorder
-
GigaCloud Technology Inc Announces Fourth Quarter and Year Ended December 31, 2025 Financial Results
-
Tecnoglass Reports Fourth Quarter and Full Year 2025 Results
-
TScan Therapeutics Completes Enrollment in Cohort C of Phase 1 ALLOHA™ Trial and Announces FDA Clearance of Investigational New Drug Applications for Heme Candidates TSC-102-A01 and TSC-102-A03
-
Kyivstar Group Board Members Visit Ukraine on the Fourth Anniversary of the Full-Scale War
-
Fractyl Health Completes Randomization in REMAIN-1 Pivotal Cohort of Revita® for Post-GLP-1 Weight Maintenance
-
Macerich to Present at Citi’s 2026 31st Annual Global Property CEO Conference
-
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Business Update
-
Liquidia Corporation to Report Full Year 2025 Financial Results on March 5, 2026
-
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
-
Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
-
Calian and ADGA Group Sign Collaborative Agreement to Advance Next-Generation Land Training and Simulation for the Canadian Army
-
C4 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
-
PyroGenesis Confirms Successful Primary Test Campaign with Leading Battery Recycler
-
Aeluma to Participate in 38th Annual ROTH Conference
-
Aikido Security Introduces Aikido Infinite, Delivering the Industry’s First Self-Securing Software Solution
-
Entrada Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
-
Shenandoah Telecommunications Company Reports Fourth Quarter and Full Year 2025 Results
-
FactSet Schedules Second Quarter 2026 Earnings Call
-
Amphista Therapeutics presents new data demonstrating how its advanced Eclipsys® platform is delivering Targeted Glue™ degraders using novel E3 ligases into the clinic
-
Boehringer Ingelheim licenses novel oral therapeutics program for immune diseases from Sitryx Therapeutics
